Gliomatosis cerebri mimicking chemotherapy-induced leukoencephalopathy in a patient with non-Hodgkin's lymphoma

3Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Patients with hematological malignancies may develop white matter lesions, which are usually associated with chemotherapy. Magnetic resonance imaging (MRI) is the imaging modality of choice for identifying chemotherapy-induced, or toxic, leukoencephalopathy. Brain biopsy in patients with hematological malignancies suspected of sustaining toxic leukoencephalopathy has rarely been performed, because its characteristic MRI findings are considered pathognomotic. Biopsy may be indicated in atypical cases, however, and it may yield unexpected results. We describe a case with white matter lesions that developed in an elderly man treated for non-Hodgkin's lymphoma. The lesions, initially diagnosed with toxic leukoencephalopathy based on MRI findings, turned out to be gliomatosis cerebri. © 2010 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Inamasu, J., Nakatsukasa, M., Kuramae, T., Masuda, Y., Tomiyasu, K., & Yamada, T. (2010). Gliomatosis cerebri mimicking chemotherapy-induced leukoencephalopathy in a patient with non-Hodgkin’s lymphoma. Internal Medicine, 49(7), 701–705. https://doi.org/10.2169/internalmedicine.49.2729

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free